Skip to main content

Table 1 Baseline characteristics of the study population

From: Intensification of insulin therapy in patients with type 2 diabetes: a retrospective, non- interventional cohort study of patients treated with insulin glargine or biphasic human insulin in daily clinical practice

Characteristic

Control group (n = 159)

Active group (n = 142)

p-value

Sex, n (%)

   

  Male

73 (45.9)

60 (42.3)

0.523

  Female

86 (54.1)

82 (57.8)

 

Age (years)

66.7 ± 9.6

63.2 ± 10.1

0.002

BMI (kg/m 2 )

31.1 ± 8.6

29.3 ± 5.4

0.029

Height (cm)

162.8 ± 12.5

164.6 ± 8.4

0.146

Weight (kg)

80.8 ± 12.7

79.3 ± 14.2

0.331

Years diagnosed

16.0 ± 8.6

13.5 ± 7.8

0.011

Duration of monitoring period (months)

9.3 ± 1.9

9.1 ± 2.0

0.291

HbA1c (%)

8.18 ± 1.33

8.53 ± 1.29

0.019

FBG (mg/dl)

168 ± 47.2

182.6 ± 57.1

0.025

  1. Data are mean ± SD or n (%).